Shireesha Dhanireddy is an Infectious Disease physician affiliated with University of Washington. OpenAlex indexes 136 publications with 5,192 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
325 9th Ave
Seattle, WA 981042499
Telephone
206-744-3000Registry record last updated 5 Jan 2012.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
43%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor14.2%Tivicay100%Part D≥16 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.7%Descovy100%Part D≥12 patients+ 6 more classes in this area
Nervous system
18.5%Other antiepileptics6.2%Topiramate52%Levetiracetam Er25%Levetiracetam23%Part D<11 patientsGabapentinoids3.3%Gabapentin57%Pregabalin43%Part D<11 patients+ 4 more classes in this area
Cardiovascular
16.3%Statin5.8%Atorvastatin Calcium51%Rosuvastatin Calcium49%Part D<11 patientsACE inhibitor3%Lisinopril100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Partial-Oral Antibiotic Therapy for Bone and Joint Infections in People With Recent Injection Drug Use
Open Forum Infectious Diseases
2023 - Safety and Tolerability of Paxlovid (Nirmatrelvir/Ritonavir) in High-risk Patients
Clinical Infectious Diseases
2022 - The Impact of COVID-19 on HIV Care Provided via Telemedicine—Past, Present, and Future
Current HIV/AIDS Reports
2021 - Visit Trends and Factors Associated With Telemedicine Uptake Among Persons With HIV During the COVID-19 Pandemic
Open Forum Infectious Diseases
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Rainer Storb
University of Washington
Connie Celum, MD, MPH
University of Washington
Helen Chu, MD, MPH
University of Washington
Bryan Kestenbaum, MD
University of Washington
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”